Treatment Costs for Nasopharyngeal Cancer by Stages : Patients’ Experience in Sarawak General Hospital
The study investigates an average direct and indirect costs incurred by Nasopharyngeal Cancer (NPC) patients who received diagnosis, treatment and follow up in the Sarawak General Hospital, Kuching, Malaysia. A total of 299 NPC patients were randomly selected using a primary data collection approa...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
Sciedu Press
2020
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/48989/1/18100-62208-1-SM.pdf http://ir.unimas.my/id/eprint/48989/ https://www.sciedu.ca/journal/index.php/rwe/article/view/18100/11094 https://doi.org/10.5430/rwe.v11n3p26 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The study investigates an average direct and indirect costs incurred by Nasopharyngeal Cancer (NPC) patients who
received diagnosis, treatment and follow up in the Sarawak General Hospital, Kuching, Malaysia. A total of 299 NPC
patients were randomly selected using a primary data collection approach from the Sarawak General Hospital
between November 2018-March 2019. Information related to the average direct and indirect costs incurred by NPC
patients at various stages and the sources of their financial assistance throughout the treatment periods were assorted.
The study reveals that the total average cost of 169 or 56.52% of the NPC patients who received various treatment
services in the public hospital is RM13,165 against RM78,860 on 130 or 43.48% of the patients received the same
services in both public and private healthcare. Major sources of funding come from patients’ savings, family
members, medical insurances, non-profit organization or charity, company healthcare benefits, employees’ provident
fund (EPF) as well as subsidy from the government: This study suggests that the treatment cost for cancer patient is
high and hence, there is a need to establish a mechanism that can provide a free screening test for NPC as a forward
step to cancer prevention, while for policy makers to develop a more supportive initiative to address the needs of the poor patients. |
|---|